Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

Related Articles by Review for PubMed (Select 21890210)

1.

Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.

Roca A, Garcia-Esteve L, Imaz ML, Torres A, Hernández S, Botet F, Gelabert E, Subirà S, Plaza A, Valdés M, Martin-Santos R.

J Affect Disord. 2011 Dec;135(1-3):208-15. doi: 10.1016/j.jad.2011.07.022. Epub 2011 Sep 3.

PMID:
21890210
2.

Antidepressants in pregnancy: a systematic review.

Udechuku A, Nguyen T, Hill R, Szego K.

Aust N Z J Psychiatry. 2010 Nov;44(11):978-96. doi: 10.3109/00048674.2010.507543. Review.

PMID:
21034181
3.

Maternal and neonatal outcomes of elective induction of labor.

Caughey AB, Sundaram V, Kaimal AJ, Cheng YW, Gienger A, Little SE, Lee JF, Wong L, Shaffer BL, Tran SH, Padula A, McDonald KM, Long EF, Owens DK, Bravata DM.

Evid Rep Technol Assess (Full Rep). 2009 Mar;(176):1-257. Review.

4.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
5.

[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].

Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.

Encephale. 2010 Jun;36 Suppl 2:D133-8. doi: 10.1016/j.encep.2009.06.005. Epub 2009 Sep 19. Review. French.

PMID:
20513456
6.

Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.

Sie SD, Wennink JM, van Driel JJ, te Winkel AG, Boer K, Casteelen G, van Weissenbruch MM.

Arch Dis Child Fetal Neonatal Ed. 2012 Nov;97(6):F472-6. doi: 10.1136/archdischild-2011-214239. Review. Erratum in: Arch Dis Child Fetal Neonatal Ed. 2013 Mar;98(2):F180.

PMID:
23080479
7.

Selective serotonin reuptake inhibitors in pregnancy.

Bellissima V, Ververs TF, Visser GH, Gazzolo D.

Curr Med Chem. 2012;19(27):4554-61. Review.

PMID:
22876893
8.

Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.

Grigoriadis S, Vonderporten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Ross LE.

BMJ. 2014 Jan 14;348:f6932. doi: 10.1136/bmj.f6932. Review.

9.

Fluoxetine during pregnancy: impact on fetal development.

Morrison JL, Riggs KW, Rurak DW.

Reprod Fertil Dev. 2005;17(6):641-50. Review.

PMID:
16263070
10.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
11.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
12.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics.

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
13.

Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.

Grzeskowiak LE, Gilbert AL, Morrison JL.

Eur J Clin Pharmacol. 2012 May;68(5):459-67. doi: 10.1007/s00228-011-1154-9. Epub 2011 Nov 13. Review.

PMID:
22080182
14.

Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.

Malm H.

Ther Drug Monit. 2012 Dec;34(6):607-14. doi: 10.1097/FTD.0b013e31826d07ea. Review.

PMID:
23042258
15.
16.

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis.

Ross LE, Grigoriadis S, Mamisashvili L, Vonderporten EH, Roerecke M, Rehm J, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A.

JAMA Psychiatry. 2013 Apr;70(4):436-43. doi: 10.1001/jamapsychiatry.2013.684. Review.

PMID:
23446732
17.

Safety of selective serotonin reuptake inhibitors in pregnancy.

De las Cuevas C, Sanz EJ.

Curr Drug Saf. 2006 Jan;1(1):17-24. Review.

PMID:
18690911
18.

Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.

Ornoy A, Koren G.

Semin Fetal Neonatal Med. 2014 Jun;19(3):188-94. doi: 10.1016/j.siny.2013.11.007. Epub 2013 Dec 8. Review.

PMID:
24321501
19.

The effect of perinatal exposures on the infant: antidepressants and depression.

Hanley GE, Oberlander TF.

Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):37-48. doi: 10.1016/j.bpobgyn.2013.09.001. Epub 2013 Sep 18. Review.

PMID:
24100223
20.

Paediatric outcomes following intrauterine exposure to serotonin reuptake inhibitors: a systematic review.

Fenger-Grøn J, Thomsen M, Andersen KS, Nielsen RG.

Dan Med Bull. 2011 Sep;58(9):A4303. Review.

PMID:
21893008
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk